Search

Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.

Graham Cooks discusses the decade’s most exciting developments, where he thinks the field will take us next, and some personal highlights

In the Hurdles and High Jumps series, we asked experienced mentors and industry leaders to address the top challenges you're facing as a translational researcher.

Find out SomaLogic intends to revolutionize precision medicine

Life science patent specialists offer a quick start guide to protecting your intellectual property

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world

Researchers probe the relationship between cardiovascular risk factors and inner retinal thickness

Detecting biomarkers of fetal alcohol spectrum disorder in naturally shed baby teeth opens the door to diagnosis

The sound of hooves doesn’t always equate to horses; untangling the overlap between Sjögren’s syndrome and dry eye may take some nerve (imaging)

What would it mean for science as a whole if the results of a seminal Alzheimer's paper underpinning the amyloid hypothesis were fabricated?